-
EP2440191
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2440191
| EP2440191 - A THROMBIN RECEPTOR ANTAGONIST AND CLOPIDOGREL FIXED DOSE TABLET [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 27.06.2014 Database last updated on 03.09.2024 | Most recent event Tooltip | 27.06.2014 | Application deemed to be withdrawn | published on 30.07.2014 [2014/31] | Applicant(s) | For all designated states Merck Sharp & Dohme Corp. 126 East Lincoln Avenue Rahway, NJ 07065-0907 / US | [N/P] |
| Former [2012/33] | For all designated states Merck Sharp & Dohme Corp. 126 East Lincoln Avenue Rahway NJ 07065-0907 / US | ||
| Former [2012/16] | For all designated states Schering Corporation 2000 Galloping Hill Road Kenilworth, NJ 07033 / US | Inventor(s) | 01 /
BURLAGE, Rubi 2000 Galloping Hill Road Kenilworth New Jersey 07033 / US | 02 /
GAFUR, Abdul, S. 2000 Galloping Hill Road Kenilworth New Jersey 07033 / US | 03 /
DUGGIRALA, Srinivas, S. 2000 Galloping Hill Road Kenilworth New Jersey 07033 / US | [2012/16] | Representative(s) | Hussain, Deeba Merck Sharp & Dohme Corp. 120 Moorgate London, EC2M 6UR / GB | [N/P] |
| Former [2012/16] | Hussain, Deeba Merck & Co., Inc. Patent Department Hertford Road Hoddesdon Hertfordshire EN11 9BU / GB | Application number, filing date | 10724639.9 | 07.06.2010 | WO2010US37581 | Priority number, date | US20090185068P | 08.06.2009 Original published format: US 185068 P | [2012/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2010144339 | Date: | 16.12.2010 | Language: | EN | [2010/50] | Type: | A2 Application without search report | No.: | EP2440191 | Date: | 18.04.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.12.2010 takes the place of the publication of the European patent application. | [2012/16] | Search report(s) | International search report - published on: | EP | 12.05.2011 | Classification | IPC: | A61K9/24, A61K31/4365, A61K31/443, A61P7/02 | [2012/16] | CPC: |
A61K9/209 (EP,US);
A61K31/4365 (EP,US);
A61K31/443 (EP,US);
A61K9/2054 (EP,US);
A61P13/12 (EP);
A61P7/02 (EP);
A61P9/00 (EP);
A61P9/04 (EP);
A61P9/06 (EP);
| C-Set: |
A61K31/4365, A61K2300/00 (EP,US);
A61K31/443, A61K2300/00 (US,EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/16] | Title | German: | TABLETTE MIT EINER FIXEN DOSIS EINES THROMBIN-REZEPTOR-ANTAGONISTEN UND CLOPIDOGREL | [2012/16] | English: | A THROMBIN RECEPTOR ANTAGONIST AND CLOPIDOGREL FIXED DOSE TABLET | [2012/16] | French: | ANTAGONISTE DU RÉCEPTEUR DE LA THROMBINE ET COMPRIMÉ DE CLOPIDOGREL À DOSE FIXE | [2012/16] | Entry into regional phase | 09.01.2012 | National basic fee paid | 09.01.2012 | Designation fee(s) paid | 09.01.2012 | Examination fee paid | Examination procedure | 09.01.2012 | Examination requested [2012/16] | 03.08.2012 | Amendment by applicant (claims and/or description) | 14.08.2013 | Despatch of a communication from the examining division (Time limit: M06) | 25.02.2014 | Application deemed to be withdrawn, date of legal effect [2014/31] | 25.03.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2014/31] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 14.08.2013 | Fees paid | Renewal fee | 31.03.2012 | Renewal fee patent year 03 | 31.03.2013 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2007117621 (SCHERING CORP [US], et al) [Y] 1-15 * claims 3,16 * * page 18, line 29 - page 19, line 8 *; | [A]WO2007115305 (COGENTUS PHARMACEUTICALS INC [US], et al) [A] 1-15 * paragraph [0207] - paragraph [0209] * * paragraph [0102] - paragraph [0103] *; | [AD]US2008031943 (GUPTA RAJAN [US], et al) [AD] 1-15 * tables 1-3 *; | [AD]WO2006044548 (REDDYS LAB LTD DR [IN], et al) [AD] 1-15 * example 2 * | [Y] - STANIFORTH J N ET AL, "PHYSICO-CHEMICAL PROPERTIES OF SILICIFIED MICROCRYSTALLINE CELLULOSE IN COMPARISON WITH MICROCRYSTALLINE CELLULOSE/SILICA BLENDS", PHARMACEUTICAL RESEARCH, KLUWER ACADEMIC PUBLISHERS, NEW YORK, NY, US, (19971102), vol. 14, no. 11, SUPPL, ISSN 0724-8741, page S201, XP009007883 [Y] 1-15 * the whole document * | Examination | US2003206978 | by applicant | US7304078 | US2004192753 | US7235567 | US2008026050 | US2008031943 | US2008152712 | US2007202140 | US2008234236 | US6063847 | US6326380 | US6645987 | US2003203927 | US2004216437 | US2004152736 | US2003216437 | US4847265 | WO2006044548 |